@prefix : <http://www.s-cubed.dk/ZINVESTDEV_T2DM/V1#> .
@prefix pr: <http://www.assero.co.uk/Protocol#> .
@prefix isoC: <http://www.assero.co.uk/ISO11179Concepts#> .
@prefix isoT: <http://www.assero.co.uk/ISO11179Types#> .
@prefix isoR: <http://www.assero.co.uk/ISO11179Registration#> .
@prefix isoI: <http://www.assero.co.uk/ISO11179Identification#> .
@prefix bo: <http://www.assero.co.uk/BusinessOperational#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .

<http://www.s-cubed.dk/ZINVESTDEV_T2DM/V1>
	rdf:type owl:Ontology ;
.
<http://www.assero.co.uk/EP#563196bd-6c15-4f30-87d5-8b821495981b>
	rdf:type pr:Epoch ;
	isoC:label "Screening"^^xsd:string ;
	pr:ordinal "1"^^xsd:integer ;
.
<http://www.assero.co.uk/EP#90538ceb-eefe-440e-93a4-66612eda7cc1>
	rdf:type pr:Epoch ;
	isoC:label "Supportive Care | Exercise-led Phase"^^xsd:string ;
	pr:ordinal "2"^^xsd:integer ;
.
<http://www.assero.co.uk/EP#333fe219-dcd9-47a4-84d1-874c4595007f>
	rdf:type pr:Epoch ;
	isoC:label "Follow-Up | Home-based Phase"^^xsd:string ;
	pr:ordinal "3"^^xsd:integer ;
.
<http://www.assero.co.uk/ARM#2602b39d-66c6-4455-8586-990c60d270a4>
	rdf:type pr:Arm ;
	isoC:label "rtCGM"^^xsd:string ;
	pr:description "Real-time Continuous Glucose Monitoring"^^xsd:string ;
	pr:armType ""^^xsd:string ;
	pr:ordinal "1"^^xsd:integer ;
.
<http://www.assero.co.uk/ARM#0e2e97cf-9e37-4425-922e-fe87d608c750>
	rdf:type pr:Arm ;
	isoC:label "isCGM"^^xsd:string ;
	pr:description "Intermittent scan (flash) Continuous Glucose Monitoring"^^xsd:string ;
	pr:armType ""^^xsd:string ;
	pr:ordinal "2"^^xsd:integer ;
.
<http://www.assero.co.uk/ELE#0f42eab3-8bf8-4820-9ef1-5f2024a0f3c0>
	rdf:type pr:Element ;
	isoC:label "Screening"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#2602b39d-66c6-4455-8586-990c60d270a4> ;
	pr:inEpoch <http://www.assero.co.uk/EP#563196bd-6c15-4f30-87d5-8b821495981b> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#1f2a1baf-20c7-4ffd-af4d-3c53bdd50f7c> ;
.
<http://www.assero.co.uk/ELE#29263403-25a6-40df-910b-7355ef0b39fb>
	rdf:type pr:Element ;
	isoC:label "Screening"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#0e2e97cf-9e37-4425-922e-fe87d608c750> ;
	pr:inEpoch <http://www.assero.co.uk/EP#90538ceb-eefe-440e-93a4-66612eda7cc1> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#1f2a1baf-20c7-4ffd-af4d-3c53bdd50f7c> ;
.
<http://www.assero.co.uk/ELE#c4769c89-7026-4dd7-923e-8a8e3f42a145>
	rdf:type pr:Element ;
	isoC:label "Exercise Led Phase"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#2602b39d-66c6-4455-8586-990c60d270a4> ;
	pr:inEpoch <http://www.assero.co.uk/EP#90538ceb-eefe-440e-93a4-66612eda7cc1> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#8cd41f82-8ba2-4847-8b3f-ec3208226d29> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#77b4010e-1230-461f-b352-803be57e22b2> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#770a3e48-8e5b-45ef-87c1-919492882005> ;
.
<http://www.assero.co.uk/ELE#f05c8001-d4a6-4df1-b649-3c8dd39cbb37>
	rdf:type pr:Element ;
	isoC:label "Exercise Led Phase"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#0e2e97cf-9e37-4425-922e-fe87d608c750> ;
	pr:inEpoch <http://www.assero.co.uk/EP#90538ceb-eefe-440e-93a4-66612eda7cc1> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#8cd41f82-8ba2-4847-8b3f-ec3208226d29> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#77b4010e-1230-461f-b352-803be57e22b2> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#770a3e48-8e5b-45ef-87c1-919492882005> ;
.
<http://www.assero.co.uk/ELE#94f73faf-f357-4d8a-bc57-ada7b1fe35ed>
	rdf:type pr:Element ;
	isoC:label "Home-based Phase"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#2602b39d-66c6-4455-8586-990c60d270a4> ;
	pr:inEpoch <http://www.assero.co.uk/EP#333fe219-dcd9-47a4-84d1-874c4595007f> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#d0f2a1d7-df8e-4e75-aa75-2e820cf93354> ;
.
<http://www.assero.co.uk/ELE#e742ed36-3dfe-4179-a8f4-12f0372c7509>
	rdf:type pr:Element ;
	isoC:label "Home-based Phase"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#0e2e97cf-9e37-4425-922e-fe87d608c750> ;
	pr:inEpoch <http://www.assero.co.uk/EP#333fe219-dcd9-47a4-84d1-874c4595007f> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#d0f2a1d7-df8e-4e75-aa75-2e820cf93354> ;
.
:PR
	rdf:type pr:Protocol ;
	isoC:label "ZINVESTDEV Type 2 Diabetes"^^xsd:string ;
	isoT:hasState :PR_RS ;
	isoT:hasIdentifier :PR_SI ;
	isoT:origin ""^^xsd:string ;
	isoT:changeDescription ""^^xsd:string ;
	isoT:creationDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoT:lastChangeDate "2021-03-13T10:46:57+01:00"^^xsd:dateTime ;
	isoT:explanatoryComment ""^^xsd:string ;
	pr:acronym "ZINVESTDEV T2"^^xsd:string ;
	pr:title "The aim of this investigator's study is to compare real-time continuous glucose monitoring (rtCGM) and flash glucose monitoring (isCGM) in adult patients with Type 1 or Type 2 Diabetes during a 14-day training program focused on physical activity and over 4 or 6 weeks of follow-up at home"^^xsd:string ;
	pr:shortTitle "ZINVESTDEV"^^xsd:string ;
	pr:studyPhase :PR_TUC3 ;
	pr:studyType :PR_TUC4 ;
	pr:interventionModel :PR_TUC1 ;
	pr:masking :PR_TUC2 ;
	pr:forIndication <http://www.s-cubed.dk/IND_TYPE_2_DIABETES_MELLITUS/V1#IND> ;
	pr:inTa <http://www.s-cubed.dk/TA_M/V1#TA> ;
	pr:specifiesArm <http://www.assero.co.uk/ARM#2602b39d-66c6-4455-8586-990c60d270a4> ;
	pr:specifiesArm <http://www.assero.co.uk/ARM#0e2e97cf-9e37-4425-922e-fe87d608c750> ;
	pr:specifiesEpoch <http://www.assero.co.uk/EP#563196bd-6c15-4f30-87d5-8b821495981b> ;
	pr:specifiesEpoch <http://www.assero.co.uk/EP#90538ceb-eefe-440e-93a4-66612eda7cc1> ;
	pr:specifiesEpoch <http://www.assero.co.uk/EP#333fe219-dcd9-47a4-84d1-874c4595007f> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#a4eab4a8-f5f4-48f6-a725-7f7c796f62d2> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#d78c669f-6ce6-4508-9296-c912f0e52d2f> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#cc8bda42-7a30-454c-9b49-26ad7d710523> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#22336869-d2f2-4d71-83f9-e535a9623f40> ;
.
:PR_RS
	rdf:type isoR:RegistrationState ;
	isoR:registrationStatus "Incomplete"^^xsd:string ;
	isoR:administrativeNote ""^^xsd:string ;
	isoR:effectiveDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoR:untilDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoR:unresolvedIssue ""^^xsd:string ;
	isoR:administrativeStatus ""^^xsd:string ;
	isoR:previousState "Incomplete"^^xsd:string ;
	isoR:multipleEdit "false"^^xsd:boolean ;
	isoR:byAuthority <http://www.assero.co.uk/RA#DUNS123456789> ;
.
:PR_SI
	rdf:type isoI:ScopedIdentifier ;
	isoI:identifier "ZINVESTDEV T2DM"^^xsd:string ;
	isoI:versionLabel ""^^xsd:string ;
	isoI:version "1"^^xsd:positiveInteger ;
	isoI:semanticVersion "0.1.0"^^xsd:string ;
	isoI:hasScope <http://www.assero.co.uk/NS#SCUBED> ;
.
:PR_TUC3
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "3"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C66737/V38#C66737_C48660> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
:PR_TUC4
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "4"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C99077/V28#C99077_C98388> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
:PR_TUC1
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "1"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C99076/V55#C99076_C82639> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
:PR_TUC2
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "2"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C66735/V4#C66735_C49659> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
<http://www.s-cubed.dk/ZINVESTDEV_T2DM_STUDY/V1#ST>
	rdf:type pr:Study ;
	isoC:label "Study for the ZINVESTDEV protocol"^^xsd:string ;
	isoT:hasState <http://www.s-cubed.dk/ZINVESTDEV_T2DM_STUDY/V1#ST_RS> ;
	isoT:hasIdentifier <http://www.s-cubed.dk/ZINVESTDEV_T2DM_STUDY/V1#ST_SI> ;
	isoT:origin ""^^xsd:string ;
	isoT:changeDescription ""^^xsd:string ;
	isoT:creationDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoT:lastChangeDate "2021-03-13T10:46:57+01:00"^^xsd:dateTime ;
	isoT:explanatoryComment ""^^xsd:string ;
	pr:description "Not set yet."^^xsd:string ;
	pr:implements :PR ;
.
<http://www.s-cubed.dk/ZINVESTDEV_T2DM_STUDY/V1#ST_RS>
	rdf:type isoR:RegistrationState ;
	isoR:registrationStatus "Incomplete"^^xsd:string ;
	isoR:administrativeNote ""^^xsd:string ;
	isoR:effectiveDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoR:untilDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoR:unresolvedIssue ""^^xsd:string ;
	isoR:administrativeStatus ""^^xsd:string ;
	isoR:previousState "Incomplete"^^xsd:string ;
	isoR:multipleEdit "false"^^xsd:boolean ;
	isoR:byAuthority <http://www.assero.co.uk/RA#DUNS123456789> ;
.
<http://www.s-cubed.dk/ZINVESTDEV_T2DM_STUDY/V1#ST_SI>
	rdf:type isoI:ScopedIdentifier ;
	isoI:identifier "ZINVESTDEV T2DM STUDY"^^xsd:string ;
	isoI:versionLabel ""^^xsd:string ;
	isoI:version "1"^^xsd:positiveInteger ;
	isoI:semanticVersion "0.1.0"^^xsd:string ;
	isoI:hasScope <http://www.assero.co.uk/NS#SCUBED> ;
.
<http://www.assero.co.uk/VI#43a4674c8dbb9a7a54fca337c8685f379ae67724>
	rdf:type pr:Visit ;
	isoC:label "Run-in"^^xsd:string ;
	pr:shortName "Vis#01"^^xsd:string ;
.
<http://www.assero.co.uk/VI#26b1c771fb3760f35a954cc6f948de851dfae630>
	rdf:type pr:Visit ;
	isoC:label "Baseline"^^xsd:string ;
	pr:shortName "Vis#02"^^xsd:string ;
.
<http://www.assero.co.uk/VI#24dc77d16170cb26034f547e8b7ac56f1a0f2a13>
	rdf:type pr:Visit ;
	isoC:label "Week 1"^^xsd:string ;
	pr:shortName "Vis#03"^^xsd:string ;
.
<http://www.assero.co.uk/VI#3ea4f410ece4b621097a543af2a7097e53ef1f95>
	rdf:type pr:Visit ;
	isoC:label "Week 2"^^xsd:string ;
	pr:shortName "Vis#04"^^xsd:string ;
.
<http://www.assero.co.uk/VI#d75c7fe12a17dd078cf0c882a4005b67d538b0bb>
	rdf:type pr:Visit ;
	isoC:label "Week 6"^^xsd:string ;
	pr:shortName "Vis#05"^^xsd:string ;
.
<http://www.assero.co.uk/TP#1f2a1baf-20c7-4ffd-af4d-3c53bdd50f7c>
	rdf:type pr:Timepoint ;
	isoC:label "TP1"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_3bb8eed2-2a03-4d76-9df6-cc75ac822a8b> ;
	pr:inVisit <http://www.assero.co.uk/VI#43a4674c8dbb9a7a54fca337c8685f379ae67724> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#23d6061a-b55a-4bcf-af3b-f44a6d6d5f07> ;
.
<http://www.assero.co.uk/TP#8cd41f82-8ba2-4847-8b3f-ec3208226d29>
	rdf:type pr:Timepoint ;
	isoC:label "TP2"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_2ae1ef9c-611b-43e4-ba3d-1058ba8589c0> ;
	pr:inVisit <http://www.assero.co.uk/VI#26b1c771fb3760f35a954cc6f948de851dfae630> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#68c3d20e-6565-4d12-a45d-7e9f092add4d> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#4f23df93-d4dc-4143-895c-c65830e8a5a8> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#818ffce3-9ec8-49ca-be39-65fd6e20865d> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#65e19978-57bf-40f0-8f34-d2ebb75ac527> ;
.
<http://www.assero.co.uk/TP#77b4010e-1230-461f-b352-803be57e22b2>
	rdf:type pr:Timepoint ;
	isoC:label "TP3"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_14b65123-338f-488d-9b33-e6ddf94a190e> ;
	pr:inVisit <http://www.assero.co.uk/VI#24dc77d16170cb26034f547e8b7ac56f1a0f2a13> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#b4a90626-1e5d-454f-8c9d-34e1f240c9ec> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#a6cd1942-648f-41cb-ae83-38916373e372> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#16a69bcd-5eec-4cce-b93e-a5b456e6a6e9> ;
.
<http://www.assero.co.uk/TP#770a3e48-8e5b-45ef-87c1-919492882005>
	rdf:type pr:Timepoint ;
	isoC:label "TP4"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_b02afc3a-923d-4a6c-86c1-01050ba6a8cb> ;
	pr:inVisit <http://www.assero.co.uk/VI#3ea4f410ece4b621097a543af2a7097e53ef1f95> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#eb30d2f3-04f9-480f-82f6-d7707f097a50> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#19a1a27b-c49f-4de4-a312-86e1fa3b6853> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#180b4b9e-9689-4004-acea-9852ee7e7866> ;
.
<http://www.assero.co.uk/TP#d0f2a1d7-df8e-4e75-aa75-2e820cf93354>
	rdf:type pr:Timepoint ;
	isoC:label "TP5"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_983b98fe-9602-4ae1-b661-24d954962f8f> ;
	pr:inVisit <http://www.assero.co.uk/VI#d75c7fe12a17dd078cf0c882a4005b67d538b0bb> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#21e755bd-596c-4302-a92f-40d2a4209a90> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#fdee11d8-1eb9-4d2d-96b7-0366816c5c2f> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#1a1ee00e-4dd6-473b-827f-11ac80b46439> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#f092ff05-c0ff-4d2b-9d2c-4d07f67d0447> ;
.
<http://www.assero.co.uk/IC#TPO_3bb8eed2-2a03-4d76-9df6-cc75ac822a8b>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "-86400"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Day"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_2ae1ef9c-611b-43e4-ba3d-1058ba8589c0>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "86400"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Day"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_14b65123-338f-488d-9b33-e6ddf94a190e>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "604800"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Day"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_b02afc3a-923d-4a6c-86c1-01050ba6a8cb>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "1209600"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Day"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_983b98fe-9602-4ae1-b661-24d954962f8f>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "3628800"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Day"^^xsd:string ;
.
<http://www.assero.co.uk/PROBJ#a4eab4a8-f5f4-48f6-a725-7f7c796f62d2>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ1"^^xsd:string ;
	pr:fullText "To assess the effect of Xanomeline Transdermal Therapeutic System (TTS) on the ADAS-Cog and CIBIC+ scores at Week 24 in participants with Mild to Moderate Alzheimer’s Disease"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_1/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#f14c4ca9-b028-4526-be15-4bb5315c8f85> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#4388244e-276d-49d4-8f16-d356f1d7753d> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#a9a96ec019494d5b8b041c1d2468061ae66e35d5> ;
.
<http://www.assero.co.uk/PROBJ#d78c669f-6ce6-4508-9296-c912f0e52d2f>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ2"^^xsd:string ;
	pr:fullText "To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these areas"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_3/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#e275b3a0-f23d-4acc-a927-a29547c668fc> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#a9a96ec019494d5b8b041c1d2468061ae66e35d5> ;
.
<http://www.assero.co.uk/PROBJ#cc8bda42-7a30-454c-9b49-26ad7d710523>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ3"^^xsd:string ;
	pr:fullText "To document the safety profile of the xanomeline TTS."^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_4/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#b9082352-09b7-4f60-a6cd-49b34aa847dd> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#46b9cc56-714b-453b-87f9-2ca0a92f7a23> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#6652489e-7baa-4ca8-810b-4d4887dbb99d> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#75e19060-49de-4a5c-96a0-21e5a2fbfce4> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#b710a1f98200b22b534bf1269c5fa2c84e1b6d82> ;
.
<http://www.assero.co.uk/PROBJ#22336869-d2f2-4d71-83f9-e535a9623f40>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ4"^^xsd:string ;
	pr:fullText "To assess the effect of xanomeline TTS on the measure of behavioral/neuropsychiatric symptoms in participants with  Alzheimer’s Disease"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_5/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#c8ca62c8-67c1-473c-8df7-86c1afa08b8e> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#b710a1f98200b22b534bf1269c5fa2c84e1b6d82> ;
.
<http://www.assero.co.uk/PROBJ#9b2d584e-0d7d-49a4-b6ed-39bd0045bab5>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ5"^^xsd:string ;
	pr:fullText "To assess the dose-dependent improvements in activities of daily living. Improved scores on the Disability Assessment for Dementia (DAD) will indicate improvement in these areas"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_6/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#db0432e9-81b8-49d7-a13c-dfadb95fa1c4> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#b710a1f98200b22b534bf1269c5fa2c84e1b6d82> ;
.
<http://www.assero.co.uk/PREND#f14c4ca9-b028-4526-be15-4bb5315c8f85>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP1"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8, 16 and 24 in the Alzheimer’s Disease Assessment Scale – Cognitive Assessment (ADAS-Cog) 14 total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_1/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#1f2a1baf-20c7-4ffd-af4d-3c53bdd50f7c> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#8cd41f82-8ba2-4847-8b3f-ec3208226d29> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#770a3e48-8e5b-45ef-87c1-919492882005> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#d0f2a1d7-df8e-4e75-aa75-2e820cf93354> ;
.
<http://www.assero.co.uk/PREND#4388244e-276d-49d4-8f16-d356f1d7753d>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP2"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8, 16 and 24 in the Clinician’s Interview-Based Impression of Change plus caregiver input (CIBIC+)"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_2/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#1f2a1baf-20c7-4ffd-af4d-3c53bdd50f7c> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#8cd41f82-8ba2-4847-8b3f-ec3208226d29> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#770a3e48-8e5b-45ef-87c1-919492882005> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#d0f2a1d7-df8e-4e75-aa75-2e820cf93354> ;
.
<http://www.assero.co.uk/PREND#e275b3a0-f23d-4acc-a927-a29547c668fc>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP3"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in the Neuropsychiatric Inventory (NPI) total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_9/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#1f2a1baf-20c7-4ffd-af4d-3c53bdd50f7c> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#8cd41f82-8ba2-4847-8b3f-ec3208226d29> ;
.
<http://www.assero.co.uk/PREND#b9082352-09b7-4f60-a6cd-49b34aa847dd>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP4"^^xsd:string ;
	pr:fullText "The proportion of participants with adverse events, serious adverse events (SAEs), and adverse events leading to study intervention discontinuation over the 24-week study intervention period"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_5/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#d0f2a1d7-df8e-4e75-aa75-2e820cf93354> ;
.
<http://www.assero.co.uk/PREND#46b9cc56-714b-453b-87f9-2ca0a92f7a23>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP5"^^xsd:string ;
	pr:fullText "The change from baseline to Week 12 in continuous laboratory tests: Hepatic Function Panel"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_6/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#1f2a1baf-20c7-4ffd-af4d-3c53bdd50f7c> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#77b4010e-1230-461f-b352-803be57e22b2> ;
.
<http://www.assero.co.uk/PREND#6652489e-7baa-4ca8-810b-4d4887dbb99d>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP6"^^xsd:string ;
	pr:fullText "The proportion of participants with abnormal (high or low) laboratory measures (urinalysis) during the postrandomization phase"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_7/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#8cd41f82-8ba2-4847-8b3f-ec3208226d29> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#77b4010e-1230-461f-b352-803be57e22b2> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#770a3e48-8e5b-45ef-87c1-919492882005> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#d0f2a1d7-df8e-4e75-aa75-2e820cf93354> ;
.
<http://www.assero.co.uk/PREND#75e19060-49de-4a5c-96a0-21e5a2fbfce4>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP7"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in ECG parameter: QTcF"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_8/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#1f2a1baf-20c7-4ffd-af4d-3c53bdd50f7c> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#8cd41f82-8ba2-4847-8b3f-ec3208226d29> ;
.
<http://www.assero.co.uk/PREND#c8ca62c8-67c1-473c-8df7-86c1afa08b8e>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP8"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in the Neuropsychiatric Inventory (NPI) total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_9/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#1f2a1baf-20c7-4ffd-af4d-3c53bdd50f7c> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#8cd41f82-8ba2-4847-8b3f-ec3208226d29> ;
.
<http://www.assero.co.uk/PREND#db0432e9-81b8-49d7-a13c-dfadb95fa1c4>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP9"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in the DAD total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_9/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#1f2a1baf-20c7-4ffd-af4d-3c53bdd50f7c> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#8cd41f82-8ba2-4847-8b3f-ec3208226d29> ;
.
<http://www.assero.co.uk/STFRM#23d6061a-b55a-4bcf-af3b-f44a6d6d5f07>
	rdf:type pr:StudyForm ;
	isoC:label "Informed Consent"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/INFORMED_CONSENT_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#68c3d20e-6565-4d12-a45d-7e9f092add4d>
	rdf:type pr:StudyForm ;
	isoC:label "Device Allocation"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/DEVICE_ALLOC_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#4f23df93-d4dc-4143-895c-c65830e8a5a8>
	rdf:type pr:StudyForm ;
	isoC:label "CGM Running"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/CGM_RUNNING_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#818ffce3-9ec8-49ca-be39-65fd6e20865d>
	rdf:type pr:StudyForm ;
	isoC:label "Adverse Events"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/AE_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#65e19978-57bf-40f0-8f34-d2ebb75ac527>
	rdf:type pr:StudyForm ;
	isoC:label "Hypoglycaemic Event"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HYPO_FORM/V1#F> ;
.
<http://www.assero.co.uk/STFRM#b4a90626-1e5d-454f-8c9d-34e1f240c9ec>
	rdf:type pr:StudyForm ;
	isoC:label "CGM Running"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/CGM_RUNNING_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#a6cd1942-648f-41cb-ae83-38916373e372>
	rdf:type pr:StudyForm ;
	isoC:label "Adverse Events"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/AE_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#16a69bcd-5eec-4cce-b93e-a5b456e6a6e9>
	rdf:type pr:StudyForm ;
	isoC:label "Hypoglycaemic Event"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HYPO_FORM/V1#F> ;
.
<http://www.assero.co.uk/STFRM#eb30d2f3-04f9-480f-82f6-d7707f097a50>
	rdf:type pr:StudyForm ;
	isoC:label "CGM Running"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/CGM_RUNNING_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#19a1a27b-c49f-4de4-a312-86e1fa3b6853>
	rdf:type pr:StudyForm ;
	isoC:label "Adverse Events"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/AE_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#180b4b9e-9689-4004-acea-9852ee7e7866>
	rdf:type pr:StudyForm ;
	isoC:label "Hypoglycaemic Event"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HYPO_FORM/V1#F> ;
.
<http://www.assero.co.uk/STFRM#21e755bd-596c-4302-a92f-40d2a4209a90>
	rdf:type pr:StudyForm ;
	isoC:label "CGM Running"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/CGM_RUNNING_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#fdee11d8-1eb9-4d2d-96b7-0366816c5c2f>
	rdf:type pr:StudyForm ;
	isoC:label "Adverse Events"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/AE_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#1a1ee00e-4dd6-473b-827f-11ac80b46439>
	rdf:type pr:StudyForm ;
	isoC:label "Hypoglycaemic Event"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HYPO_FORM/V1#F> ;
.
<http://www.assero.co.uk/STFRM#f092ff05-c0ff-4d2b-9d2c-4d07f67d0447>
	rdf:type pr:StudyForm ;
	isoC:label "Termination Record"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/TERMINATION_DEMO/V1#F> ;
.